Download Citation
Article Source:
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
Zhang H,
Yang Y,
Li J,
Wang M,
Saravanan KM,
et al.
(2020)
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.
PLOS Computational Biology 16(12): e1008489.
https://doi.org/10.1371/journal.pcbi.1008489